Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF TRAP: a procedure to improve laboratory testing with myelography.

R E Albright1, R H Christenson, M C Bledsoe

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Neurosurgery
|July 1, 1989
PubMed
Summary

This study introduces a new method called CSF TRAP to improve how cerebrospinal fluid (CSF) is handled during spinal imaging procedures like myelography. The goal is to reduce unnecessary testing while ensuring important diagnostic tests are still available when needed. The researchers found that for most patients, additional CSF tests like cultures or cytology don't provide useful information. However, for patients with cancer or multiple sclerosis, these tests can be valuable. By using CSF TRAP, clinicians can review initial results before ordering further tests, which helps avoid unnecessary procedures. This approach reduced the number of CSF tests by 20%, saving over $14,000 in costs. The study suggests that this method could help labs save money without missing critical diagnostic information.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.

Contemporary clinical trials communications·2019
Same author

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Recommendation to harmonize the units for reporting cardiac troponin results.

Clinica chimica acta; international journal of clinical chemistry·2013
Same author

[The ways of harmonization of clinical laboratory measurement techniques].

Klinicheskaia laboratornaia diagnostika·2013
Same author

Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction.

Cardiovascular toxicology·2002
Same author

Determination of the falloff constant (k(f)) from modeling biochemical marker release: a new variable for discriminating therapies.

Cardiovascular toxicology·2002

Area of Science:

  • Neurological diagnostic procedures
  • Clinical laboratory practices

Background:

Current practices in spinal imaging often involve myelography, which produces cerebrospinal fluid (CSF) samples for additional testing. However, not all patients benefit from extensive CSF analysis. Prior research has shown that many CSF tests, such as cultures or cytology, yield little useful information in patients with non-cancerous or non-neurological conditions. That uncertainty drove the need to evaluate procedures that could reduce unnecessary testing while maintaining diagnostic value. No prior work had resolved how to optimize CSF use in myelography without compromising diagnostic accuracy. This gap motivated the development of a new approach to manage CSF specimens. The goal is to address the inefficiency of current testing protocols. This paper introduces a novel procedure to streamline CSF testing. The procedure aims to improve cost-effectiveness without sacrificing clinical utility. By focusing on high-yield tests, it may help reduce unnecessary expenditures in diagnostic labs.

Purpose Of The Study:

The study aimed to assess the cost-effectiveness of a new procedure called CSF TRAP during myelography. Myelography involves injecting contrast into the spinal canal and often produces CSF samples for analysis. The researchers wanted to determine if eliminating low-yield tests on CSF could reduce costs without harming patient care. The procedure allows clinicians to review initial findings before deciding on additional tests. This approach may help avoid unnecessary testing in patients with conditions unlikely to benefit from it. The study focused on patients with disc diseases, spinal stenosis, and other spinal conditions. It also included patients with cancer and neurological disorders. The researchers sought to quantify the financial impact of this new method on laboratory testing.

Keywords:
cerebrospinal fluid testingmyelography procedurelaboratory cost savingsdiagnostic accuracy

Frequently Asked Questions

CSF TRAP is a procedure that stores cerebrospinal fluid for rapid access and allows clinicians to review initial findings before ordering additional tests.

Patients with cancer and those with multiple sclerosis benefit most from additional CSF tests like cytology and oligoclonal band analysis.

These tests were eliminated for patients with disc diseases, spinal stenosis, and pain syndromes because they rarely provided useful clinical information.

The procedure maintains diagnostic accuracy by preserving CSF for high-yield tests while reducing unnecessary low-yield studies.

Related Experiment Videos

Main Methods:

The study evaluated the CSF TRAP procedure in a group of 819 patients who underwent myelography. The procedure involves storing CSF specimens for later use and allowing rapid access to them. Clinicians reviewed initial findings before ordering additional tests. The study group included patients with disc diseases, spinal stenosis, spondylolisthesis, and pain syndromes. Ten percent of the patients had cancer, and 16% had neuropathies or other conditions. The researchers compared the number of tests performed before and after implementing CSF TRAP. They focused on eliminating unnecessary culture and cytology tests in patients unlikely to benefit from them. The cost savings were calculated based on the reduction in low-yield procedures.

Main Results:

The study found that routine CSF testing provided little clinical benefit for most patients. Only patients with cancer and those with multiple sclerosis showed significant diagnostic value from additional tests. Of 80 cancer patients, 12 had positive cytology results in their CSF. For multiple sclerosis patients, oligoclonal band and IgG analysis provided supportive data. The CSF TRAP procedure reduced unnecessary testing in patients with disc diseases, spinal stenosis, spondylolisthesis, and pain syndromes. This change led to a 20% reduction in myelographic CSF procedures. The cost savings exceeded $14,000. The procedure allowed for selective testing based on initial findings. It preserved the ability to perform high-yield tests when needed.

Conclusions:

The authors suggest that the CSF TRAP procedure may improve the efficiency of laboratory testing during myelography. By eliminating unnecessary tests on patients unlikely to benefit from them, the procedure may reduce costs without compromising diagnostic accuracy. The findings indicate that routine CSF testing provides little value in most cases. However, for patients with cancer or multiple sclerosis, additional tests remain important. The researchers propose that selective testing based on initial findings may be more cost-effective. The procedure allows clinicians to review results before ordering further tests. The study implies that the CSF TRAP approach could be useful in settings where CSF testing is routine. It may help reduce unnecessary expenditures in diagnostic laboratories.

The procedure reduced myelographic CSF procedures by 20%, resulting in savings exceeding $14,000.

The authors suggest that selective CSF testing based on initial findings may improve cost-effectiveness without compromising diagnostic accuracy.